Fact-check: “Dupixent cures asthma”
Verdict: False (98% confidence)
Every primary source — the FDA-approved label, EMA product information, pivotal clinical trials, and professional society guidelines — consistently describes Dupixent as an add-on maintenance treatment that reduces exacerbations and improves lung function in certain asthma phenotypes, not as a cure. The FDA label explicitly frames it as ongoing maintenance therapy, and the NHLBI states plainly that there is no cure for asthma. No regulatory document, clinical trial, or guideline uses the word '…
This fact-check was conducted by SpinkillerAI, a non-partisan AI-powered accountability platform.
Related fact-checks
- Donald Trump Jr accepted a gift from a Russian oligearch — True
- European Union plans 200 million Euro investment in Greenland as a response to Trump's posturing — Mostly True
- Approximately 45% of the current Canadian population is made up of immigrants and the children of immigrants — Mostly True
- Recent job numbers increased faster than had been expected and are ahead of most analysts expectations — Partly True
- Medicare for all would cost trillions a year that Americans would pay through higher income taxes — Partly True